Pure Global

Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling - Trial NCT06259448

Access comprehensive clinical trial information for NCT06259448 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Bordeaux and is currently Recruiting. The study focuses on Cervical Cancer. Target enrollment is 170 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06259448
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06259448
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling

Study Focus

Cervical Cancer

urine self-sampling

Interventional

other

Sponsor & Location

University Hospital, Bordeaux

Bordeaux, France

Timeline & Enrollment

N/A

Nov 13, 2023

Nov 01, 2024

170 participants

Primary Outcome

Urine self-sampling acceptability

Summary

This project addresses the issue of promoting organized cervical cancer screening (CCS) from
 the perspective of the use of urine self-sampling (USS). Via a prospective and monocentric
 study, the present study aims to evaluate the acceptability of women to collect a urine
 self-sample and to respond to a questionnaire on their feelings about this screening method.

ICD-10 Classifications

Severe cervical dysplasia, not elsewhere classified
Mild cervical dysplasia
Moderate cervical dysplasia
Carcinoma in situ: Cervix, unspecified
Cervical root disorders, not elsewhere classified

Data Source

ClinicalTrials.gov

NCT06259448

Non-Device Trial